Literature DB >> 10968503

Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension.

L H Steenhuis1, H J Groen, G H Koëter, T W van der Mark.   

Abstract

The transfer factor of the lung for carbon monoxide (TL,CO) is decreased in patients with pulmonary hypertension. The pulmonary membrane diffusion capacity (Dm) and pulmonary capillary blood volume (Vc), were studied to establish: 1) the relative contribution of the components of the transfer factor to the decrease in TL,CO; 2) whether differences exist between primary pulmonary hypertension (PPH) and chronic thromboembolic pulmonary hypertension (CTEPH); and 3) the relationship between these parameters and haemodynamic parameters. Dm and Vc were determined in 19 patients with PPH and in eight patients with CTEPH. The patients had been referred for consideration for lung transplantation. Haemodynamic parameters were assessed by heart catheterization. In the PPH group, Vc was reduced in 12 of 19 patients (mean+/-SD Vc 72+/-14% of the predicted value) and Dm in 17 of 19 patients (60+/-22% pred). In the CTEPH group, Vc was reduced in six of eight patients and Dm in seven of eight patients. The mean TL,CO Dm and Vc values were similar to those in the PPH group. The reduction in pulmonary membrane diffusion capacity was significantly greater than that in pulmonary capillary blood volume. No differences in pulmonary and cardiovascular functional values were found between the groups. Right atrial pressure showed a significant negative correlation with pulmonary capillary blood volume and an increased pulmonary vascular resistance was associated with a decrease in pulmonary membrane diffusion capacity. These results suggest pronounced functional impairment of the alveolocapillary membrane in these patients.

Entities:  

Mesh:

Year:  2000        PMID: 10968503     DOI: 10.1034/j.1399-3003.2000.16b15.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

1.  Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.

Authors:  Takashi Eguchi; Sarina Bains; Ming-Ching Lee; Kay See Tan; Boris Hristov; Daniel H Buitrago; Manjit S Bains; Robert J Downey; James Huang; James M Isbell; Bernard J Park; Valerie W Rusch; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

2.  A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.

Authors:  Paul R Woods; Bryan J Taylor; Robert P Frantz; Bruce D Johnson
Journal:  Am J Cardiol       Date:  2012-01-14       Impact factor: 2.778

3.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

4.  The usefulness of submaximal exercise gas exchange to define pulmonary arterial hypertension.

Authors:  Paul R Woods; Robert P Frantz; Bryan J Taylor; Thomas P Olson; Bruce D Johnson
Journal:  J Heart Lung Transplant       Date:  2011-05-31       Impact factor: 10.247

5.  Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation.

Authors:  Nicholas M Anstey; Tjandra Handojo; Michael C F Pain; Enny Kenangalem; Emiliana Tjitra; Ric N Price; Graeme P Maguire
Journal:  J Infect Dis       Date:  2007-01-04       Impact factor: 5.226

Review 6.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 7.  Diffusing capacity.

Authors:  Matthew J Hegewald
Journal:  Clin Rev Allergy Immunol       Date:  2009-03-31       Impact factor: 8.667

8.  Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.

Authors:  Jay Suntharalingam; Rajiv D Machado; Linda D Sharples; Mark R Toshner; Karen K Sheares; Rodney J Hughes; David P Jenkins; Richard C Trembath; Nicholas W Morrell; Joanna Pepke-Zaba
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

9.  Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy.

Authors:  William R Auger; Kim M Kerr; Nick H Kim; Peter F Fedullo
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

10.  Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension.

Authors:  Samar Farha; Daniel Laskowski; Deepa George; Margaret M Park; W H Wilson Tang; Raed A Dweik; Serpil C Erzurum
Journal:  Respir Res       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.